The idea of a single obesity gene that one would have inherited from one’s parents is a seductive but false simplification. The reality, as described by research notably including Inserm, is both more complex and more interesting: there is not a single obesity gene, but a genetic architecture involving more than a thousand regions of the genome, and, in rare cases, genuine unique mutations capable on their own of causing severe obesity.
A truly real familial predisposition
First established fact: obesity is inherited, at least in part, within families.
According to Inserm, an individual has two to eight times higher odds of being obese if family members are affected.
Twin studies, which help distinguish genetic factors from shared environmental influences, have allowed estimation of the heritability of obesity at about 40–70%. This does not mean that a person’s weight is written into their DNA at birth by 40–70%, but rather that the observed weight differences between people are largely explained by genetic differences.
A common obesity of polygenic nature
For the vast majority of people with obesity, it is not a broken single gene, but a cumulative effect of many small genetic variations. Teams from Inserm and CNRS have thus identified nearly 1,000 genome regions linked to greater weight gain.
Individually, each of these variations weighs almost nothing on final weight. Even when added together, they explain only a small portion of weight differences among individuals: the real role of genetics lies primarily in how it makes certain people more sensitive to their environment (diet, physical inactivity).
This explains why, with comparable lifestyles, some people gain weight more easily than others, without this constituting absolute determinism: the genetic background influences susceptibility; it does not dictate the outcome.
The rare forms of obesity linked to a single gene
Alongside this polygenic obesity, there exist rarer forms, called monogenic, where a mutation in a single gene is enough to trigger severe and early obesity, typically from childhood. They affect about 5% of obese individuals in Western countries, a proportion higher in populations where consanguineous unions are more frequent.
These forms involve genes in the so-called leptin/melanocortin pathway, a biological circuit that regulates hunger and fullness: LEPR, POMC, PCSK1, MC4R, or MC3R. The MC4R gene is the most frequently implicated among these monogenic obesities, with more than a hundred described mutations to date in cohorts of obese children and adults.
In affected individuals, the misregulation of this pathway leads to hunger that is nearly impossible to control by willpower alone, giving rise to substantial weight gain starting in early life.
Why this distinction concretely changes management
This distinction is not merely a scientific detail: it has direct therapeutic consequences. Since 2021, Europe has offered targeted care specifically for people carrying these rare mutations in the leptin/melanocortin pathway. By acting directly on the MC4R receptor, it restores the faulty satiety signaling in these patients, with meaningful results on obesity that had been very difficult to treat.
Specialized centers for genetic obesity, such as the Pradort Rare Disease Center in France, enable identification of these rare forms through genetic testing and guidance toward this targeted management approach.
However, it has no relevance for common polygenic obesity; a personalized obesity management with healthcare professionals is then recommended.
Genetics does not mean inevitability
Whether obesity is polygenic or, more rarely, linked to a single mutation, one point deserves emphasis: genetics never acts alone. It defines susceptibility, not a fixed destiny. This is also the central aim of epigenetic research, which examines how the environment (diet, sleep, stress, in utero exposure) can modulate gene expression without altering the DNA itself.
This scientific reality has an important implication: it invalidates the common belief that obesity is solely a matter of personal will.
In summary
There is no isolated “obesity gene,” but a substantial real genetic predisposition, carried by more than a thousand common variants that interact with the environment, and, in rare cases, by unique mutations in specific genes like MC4R that can now be identified and treated specifically.
This genetic complexity confirms what medicine is increasingly recognizing: obesity is a chronic, multifactorial disease that calls for medically supervised weight management rather than moral judgment about the will of those affected.
With institutional support from the Lilly laboratory. Lilly cannot be held responsible for content published on Charles’ blog, platforms and social networks.
